Plasminogen activator inhibitor type-1 (PAI-1) polymorphism 4G/5G is associated with prostate cancer among men with a positive family history. (Q45985353)
Jump to navigation
Jump to search
scientific article published in February 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Plasminogen activator inhibitor type-1 (PAI-1) polymorphism 4G/5G is associated with prostate cancer among men with a positive family history. |
scientific article published in February 2007 |
Statements
1 reference
Plasminogen activator inhibitor type-1 (PAI-1) polymorphism 4G/5G is associated with prostate cancer among men with a positive family history. (English)
1 reference
Eric Jorgenson
1 reference
Steven R Deitcher
1 reference
Mine Cicek
1 reference
Xin Liu
1 reference
Sarah Plummer
1 reference
Graham Casey
1 reference
John S Witte
1 reference
1 February 2007
1 reference
1 reference
67
1 reference
2
1 reference
172-177
1 reference
1 reference
Identifiers
1 reference